Form 4 Filing for Beam Therapeutics Inc. - Stock Option Grant

This filing reports a stock option grant to Mark Fishman, a director at Beam Therapeutics Inc. The option, for 19,676 shares of Common Stock, was granted on June 3, 2026, with an exercise price of $29.55. The option vests in full on the earlier of the first anniversary of the grant date or immediately prior to the next annual stockholders' meeting, contingent upon continued service. The option has an expiration date of June 3, 2036. This transaction is classified as a grant of a derivative security.